Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Salicylic acid 5% w/w in emulsifying ointment		Unlicensed special
Sapropterin dihydrochloride (Kuvan)	TA729 - Sapropterin for treating hyperphenylalaninaemia in phenylketonuria
Sarilumab	TA485 - Sarilumab for moderate to severe rheumatoid arthritis
Selenium injection
Sevoflurane
Sildenafil injection		Hospital use only. NHS England commissioned.
Sildenafil tablets		Hospital use only. NHS England commissioned.
Sildenafil tablets
Siponimod (Mayzent®)	TA656 - Siponimod for treating secondary progressive multiple sclerosis
Sirolimus solution	TA85 - Immunosuppressive therapy for renal transplantation in adults	New post-transplant

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.